feed,title,long_url,short_url
Investing,Alfa Laval Q3 earnings beat expectations despite Energy division costs,https://www.investing.com/news/stock-market-news/alfa-laval-q3-earnings-beat-expectations-despite-energy-division-costs-93CH-4312313,
Investing,AstraZeneca's Koselugo approved in EU for adult neurofibromatosis,https://www.investing.com/news/stock-market-news/astrazenecas-koselugo-approved-in-eu-for-adult-neurofibromatosis-4312306,
